| Status | Study |
| Enrolling by invitation |
Study Name: An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Date: 2016-07-24 Interventions: Drug: OTX-101 0.09% 0.09% cyclosporine nanomicellar solution |
| Completed |
Study Name: Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Date: 2016-02-13 Interventions: Drug: cyclosporine Other Name: |
| Completed |
Study Name: Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Dry Eye Disease Date: 2014-09-29 Interventions: Drug: OTX-101 0.05% OTX-101 0. |
| Completed |
Study Name: A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome Condition: Keratoconjunctivitis Sicca Date: 2014-05-06 Interventions: Drug: Retaine™ |
| Completed |
Study Name: Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months Condition: Vernal Keratoconjunctivitis Healthy Children Date: 2013-11-25 Interventions: Procedure: Cytokins assay in tears |
| Recruiting |
Study Name: Topical Tacrolimus in Vernal Keratoconjunctivitis Condition: Vernal Keratoconjunctivitis Date: 2013-08-18 Interventions: Drug: Topical tacrolimus Topical tacrolimus 0.01% twice daily for one month |
| Completed |
Study Name: To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Date: 2013-07-11 Interventions: Drug: R348 Ophthalmic Solution, 0.2% |
| Completed |
Study Name: Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Date: 2013-03-21 Interventions: Drug: Lotemax Gel + Restasis O |
| Completed |
Study Name: Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Dry Eye Syndrome Date: 2013-02-21 Interventions: Drug: dexamethasone, artificial tears |
| Active, not recruiting |
Study Name: Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis Condition: Vernal Keratoconjunctivitis Date: 2012-12-13 Interventions: Drug: NOVA22007 ''Ciclosporin'' |